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Background: Thyroid cancer rates are on the rise worldwide with over 5000 new cases estimated in Canada in
2012. The American Thyroid Association recommends the use of fine-needle aspiration biopsy (FNA) in the workup
of thyroid nodules. Studies show that thyroid FNA accuracy may vary based on interpretation by cytopathologists
in academic versus community centres. To date, there has been no literature published addressing the accuracy or
utility of preoperative FNA in a Canadian community center. Our goals were to demonstrate the accuracy of thyroid
FNA at our centre, and to compare our results to those published in the literature.
Methods: Medical records for patients who underwent thyroidectomy performed by two otolaryngologists in
Fredericton, NB, between September 2008 and February 2013 were reviewed. 125 patients with 197 FNAs were
analyzed. Fisher’s Exact test was used to compare the malignancy rates in each FNA category, and Chi-Square test
was used for FNA distribution comparison.
Results: The distribution of all FNA diagnoses at our centre was as follows: 38 (19%) benign, 100 (51%) inconclusive, 8
(4%) suspicious for malignancy, 2 (1%) malignant, and 49 (25%) unsatisfactory. FNA distribution was significantly
different between our centre and comparison centres (Chi-Square p < 0.05). Our malignancy rates within each category
using each FNA sample as a data point were 26.3%, 29.0%, 75%, 100% and 12.2% respectively. Comparison to other
community studies revealed that we have significantly higher malignancy rates with benign FNAs (Fisher’s exact
p = <0.05). Analysis using our most malignant FNA data yielded similar results.
Conclusion: Thyroid FNA accuracy varies between institutions, and this may affect its utility in the workup of a thyroid
nodule at some centres. Expert cytopathology opinions may be an asset in interpreting FNA samples in small
community centres where volumes are relatively low, however our data do not support this assertion. It is essential that
physicians continue to use clinical judgment first and foremost when evaluating thyroid nodules.
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It is estimated that the incidence of thyroid cancer has
more than doubled in much of the developed world over
the past few decades. In Canada, thyroid cancer annual
incidence rates increased an average of 7% from 1998–
2007. Over 5000 new cases were diagnosed in 2012 [1].
Theories have been postulated to explain this trend. It
may be due to more frequent diagnostic imaging with an
associated increase in radiation exposure. These tests
may also be leading to the incidental discovery of earlier
stage, asymptomatic thyroid cancers [1].* Correspondence: k55arl@mun.ca
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unless otherwise stated.In the workup of thyroid nodules, one of the greatest
challenges for physicians is to accurately identify which
nodules have a high likelihood of harbouring malignant
disease; thereby minimizing unnecessary surgical proce-
dures and their associated risks in those with benign dis-
ease. The American Thyroid Association recommends
fine needle aspiration biopsy (FNA) as a key step in the
evaluation of thyroid nodules [2].
Thyroid FNA is an inexpensive, relatively safe test that
may be performed in an outpatient setting. It is used to
characterize thyroid nodules and to triage patients based
on cytopathological results. It has been shown to dem-
onstrate good specificity and sensitivity with respect to
thyroid malignancy [3-5]. Before routinely using FNA inis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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resected nodules were approximately fifteen percent; how-
ever, with current FNA practice these rates have report-
edly increased to over fifty percent in some centres [6,7].
That said, there remain numerous limitations to FNA
in the workup of thyroid nodules. For example, the skill
of the aspirator and the expertise of the interpreting cy-
tologist, both of which can vary from centre to centre,
can dramatically affect accuracy of the test. Many papers
have been published addressing this variability; however,
the vast majority of them have been done in academic
or tertiary care centres [8]. The number of studies done
in a community setting is limited [8-10], and no data
have been published from community centres in Canada.
Given that most community centres have lower volumes
than academic centres, and given that many community
specialists have little sub-specialty or fellowship training,
it is possible that the published accuracy of thyroid FNA
may not truly reflect results seen in the community,
thereby calling into question the utility of this test out-
side of tertiary centres.
As such, we decided to retrospectively review our ex-
perience at our Canadian community-based secondary
hospital. We analyzed our thyroid FNA distribution and
accuracy in the workup of thyroid nodules, and we com-
pare these results to other international community cen-
tres [8-10] and to academic practices, including our
closest major tertiary care referral centre [11].Table 1 Distribution of preoperative thyroid FNA results
as per diagnostic category
FNA Category Percent of distribution
Unsatisfactory 49/197: 24.9% 17/125: 13.6%*
Benign 38/197: 19.2% 22/125: 17.6%*
Inconclusive 100/197: 50.8% 76/125: 60.8%*
Suspicious for malignancy 8/197: 4.1% 8/125: 6.4%*
Malignant 2/197: 1.0% 2/125: 1.6%*
*using most malignant FNA for those patients with more than one preoperative FNA.
FNA: fine-needle aspiration biopsy.Methods
The medical records for all patients who underwent thy-
roidectomy, performed by two otolaryngologists at the Dr.
Everett Chalmers Hospital in Fredericton, NB, between
September 2008 and February 2013 were retrospectively
reviewed. The only patients excluded from our study were
those who did not have a preoperative FNA. Examples of
exclusions include cases of refractory hyperthyroidism and
diffuse goiter with compressive symptoms in the absence
of a dominant or suspicious nodule. A statistician was
consulted throughout the study design and data review.
A total of 125 patients with 197 FNAs were included for
analysis. The age and gender of each patient was recorded
as well as the surgical procedure performed. Initially, each
FNA was treated as a separate data point and our statis-
tical analysis was carried out. Subsequently, the data were
reorganized using only the most malignant FNA for those
with more than one preoperative FNA, and the statistics
were repeated. There lacked uniformity in reporting from
one cytopathologist to the next, and the current Bethesda
criteria were not always used. As such, the FNA results
were classified into one of the following categories, in in-
creasing order of suspicion: unsatisfactory; benign; incon-
clusive; suspicious for malignancy and malignant.The distribution of the FNA results across the five cat-
egories was calculated. Using Chi-square test, the distri-
bution at our centre was compared to data published
from four other centres. Each preoperative FNA result
was paired with the corresponding final pathological
diagnosis from the surgical specimen. Fisher’s exact test
was used for comparison of malignancy rates per FNA
category between centers. A p value of less than 0.05
was considered a statistically significant difference.
Ethics approval was provided by the Research Ethics
Board for the Horizon Health Network.
Results
In total, 197 thyroid FNA samples from 125 patients, 102
females and 23 males, were reviewed. Their ages ranged
from 15 to 78 years with a mean age of 50.10 +/− SD
13.25 years. They went on to have a diagnostic hemi-
thyroidectomy (96), a total thyroidectomy (29).
The distribution of FNA diagnoses at our centre is
demonstrated in Table 1. It shows the distribution when
each FNA was considered a separate data point, as well
as the distribution using only the most malignant FNA
in those patients with more than one preoperative FNA.
The overall rate of thyroid cancer in our study was 28.8%.
Table 2 demonstrates the rate of malignancy broken down
by FNA category, once again including rates considering all
FNA samples as distinct data points, as well as rates using
only the most malignant FNA per patient.
Our results were then compared to three community-
based centres [8-10] and one geographically close aca-
demic centre [11]. When using each FNA as a separate
data point, our overall distribution across the categories
was significantly different than all comparison centres
(Table 3). When using only the most malignant FNA
sample, the distribution at our centre remained signifi-
cantly different than all but the geographically close aca-
demic centre (Table 4).
Table 5 shows the comparison of our malignancy rates
to those of the four comparison centres using all FNA
samples as distinct data points. Table 6 shows the same
comparison using only our most malignant samples per
thyroidectomy. Malignancies per FNA category yielded
Table 2 Malignancy rates per preoperative thyroid FNA
diagnostic category
FNA Result Malignancy rates
Unsatisfactory 6/49: 12.2% 2/17: 11.8%*
Benign 10/38: 26.3% 4/22: 18.0%*
Inconclusive 29/100: 29% 22/76: 28.9%*
Suspicious for malignancy 6/8: 75% 6/8: 75%*
Malignant 2/2: 100% 2/2: 100%*
Overall 26.9% 28.8%*
*using most malignant FNA for those patients with more than one preoperative FNA.
FNA: fine-needle aspiration biopsy.
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lignancy rates in the setting of a benign FNA are signifi-
cantly higher than those at the comparison community
centres.
Discussion
Thyroid cancer rates continue to rise. Furthermore, the in-
cidence of thyroid cancer in the setting of a thyroid nodule
ranges from 20% to as low as 5%. FNA has been estab-
lished as the gold-standard procedure in the workup of
thyroid nodules to help clinicians determine whether or
not a given nodule represents malignancy. Despite being
ubiquitous in the workup of thyroid nodules in North
America, the accuracy and utility of this apparently simple
test can vary greatly from one centre to the next. In an ef-
fort to curb some of this variability, the American Thyroid
Association (ATA) has created extensive guidelines ad-
dressing the indications for FNA, and the Bethesda system
has been developed and widely accepted as the manner in
which FNA samples should be cytopathologically inter-
preted and classified.
Cibas and Ali [12] claim that the routine use of FNA in
the workup of a thyroid nodule has increased the malig-
nancy rates in resected nodules from 14% to 50%. At our
centre, we anecdotally observed a very high rate of benign
nodules being resected despite the use of FNA in the pre-
operative workup. We also felt that we were seeing an un-
usually high number of inconclusive FNAs, and we beganTable 3 Comparison of preoperative FNA distributions betwe
percentage of all preoperative FNAs




Suspicious for malignancy 7.7% 6.1%
Malignant 15.8% 2.0%
Total 34.4% 12.0%
*Chi-square p < 0.05.
FNA: fine-needle aspiration.to question the validity of FNA results at our institution.
We hypothesized that the experience of the interpreting
cytopathologists may be a contributing factor. Being a
smaller secondary hospital, our volumes are relatively low
compared to larger academic centres, and we do not have
a dedicated head & neck pathologist reviewing all of our
FNA specimens. We felt that it was possible that the
relative inexperience of our pathologists when compared
to the larger academic centres was leading to less accur-
ate results from thyroid FNAs. If academic high-volume
cytopathologists can produce more accurate and reliable
results, then it may make sense for smaller volume
centres to outsource their FNAs for interpretation by
experts in centres of excellence. Our study was not pow-
ered to evaluate differences from one cytopathologist to
the next.
In an effort to objectify our suspicions, we reviewed the
literature and studied our data over a five-year period,
comparing our results to those published. We felt it im-
portant to compare our results to those published from
similar centres; however we were surprised to find no
published studies addressing the accuracy and utility of
FNA in a Canadian community centre. All Canadian data
has been published at tertiary care hospitals. We chose
our geographically closest academic centre as one of our
comparison studies. We found three American studies
done in community centres and we included all three in
our analysis.
Our data show that only 28.8% of our resected nodules
were malignant. The malignancy rates reported in the
literature also seem to vary greatly, from as low as 12.0%
to as high as 34.4% in the papers we chose as compari-
son studies. To our surprise, our overall malignancy
rates were nearly identical to those published by our
closest academic centre, and they were not significantly
different than those published in the studies to which we
compared. While it is reassuring that we aren’t resecting
more benign disease than others, it is very difficult to at-
tribute these results to FNA accuracy as the FNA is but
one of many tools used in the decision to proceed with
surgery. Furthermore, we are still subjecting more thanen our center and other published centers shown as a







Table 4 Comparison of preoperative FNA distributions between our center and other published studies shown as a
percentage of all preoperative FNAs using the most malignant FNA per patient at our center
FNA Result Blansfield et al.* Postma et al.* Wu et al.* Williams et al. Our center
Unsatisfactory 6.0% 0% 9.5% 14.2% 13.6%
Benign 24.0% 28.6% 28.5% 24.2% 17.6%
Inconclusive 46.4% 48.0% 52.0% 53.6% 60.8%
Suspicious for malignancy 7.7% 6.1% 8.1% 4.4% 6.4%
Malignant 15.8% 2.0% 8.6% 3.6% 1.6%
Total 34.4% 12.0% 21.7% 28.4% 28.8%
*Chi-square p < 0.05.
FNA: fine-needle aspiration.
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disease.
We also found that our FNA results were inconsistent;
we felt that an unusually high percentage of our samples
were being reported as either unsatisfactory or inconclu-
sive. Our data clearly support this suspicion, as our dis-
tribution was significantly different than that of the
comparison centres. While there are many possible ex-
planations for this discrepancy, including the skill of
both the aspirator and the interpreter, it’s difficult to
clearly prove what factors are causative. But interestingly,
when using only the most malignant FNA specimen in the
analysis, our distribution was not significantly different
than that of our closest teaching centre. This calls into
question our assertion that the experience of our inter-
preting clinicians could be problematic.
Our most concerning finding is that 26.3% of our pa-
tients with FNAs that were reported as benign ultimately
had well differentiated thyroid carcinoma. By limiting our
analysis to only the most malignant specimens, that num-
ber decreases to 18.0%, still a very high false-negative rate.
These results were significantly higher that those pub-
lished at the other community centres, but interestingly
not significantly higher than those of our closest academic
centre. Wang et al., showed a statistically significant differ-
ence in false negative rates (10% vs 2%) betweenTable 5 Comparison of malignancy rates per preoperative thy
other published studies
FNA Result Blansfield et al. Postma et al.
Unsatisfactory 0/11 = 0% 0/0 = 0%
Benign 3/44 = 6.8%* 0/28 = 0%*
Inconclusive 25/85 = 29.4% 3/47 = 6%*
Suspicious for malignancy 8/14 = 57.1% 5/6 = 83%
Malignant 27/29 = 93.1% 2/2 = 100%
Total 63/183 = 34.4% 10/83 = 12.0%
*Fisher’s exact p < 0.05.
FNA: fine-needle aspiration.community and academic centers [13]. Yeh et al., demon-
strated a single false negative FNA delayed treatment by
an average of more than two years resulting in patients ex-
periencing higher rates of vascular and capsular invasion
[14]. Subsequently, such patients were more likely to ex-
perience persistent disease at follow-up. The discrepancy
between published results is difficult to conclusively ex-
plain, but selection bias may be playing a role. In our study
and in Williams et al., only patients who went on to have
thyroid surgery were included. There would have been
many FNAs reported as benign in patients that did not go
on to surgery during the study period, and thus not cap-
tured in our data set. Those that were included in our re-
view likely had other concerning clinical features that
resulted in them having surgery despite the results. A re-
view of all FNAs performed would be more useful in com-
paring malignancy rates per FNA category to published
norms. That said, our data once again refute our initial as-
sertion that academic centre cytopathologists will yield
more accurate data than those at our community centre.
A big limitation of our study is that our pathology de-
partment has not yet adopted the current Bethesda clas-
sification system, and the classification can even vary
slightly from one interpreter to the next. This is not
unique to our institution [9,10]. To compare our results
to those published, we had to re-classify some FNAs toroid FNA diagnostic category between our center and
Wu et al. Williams et al. Our study
3/21 = 14.2% 10/55 = 18.2% 6/49: 12.2%
2/63 = 3.1%* 15/94 = 16.0% 10/38: 26.3%
14/100 = 14.0% 55/208 = 26.4% 29/100: 29%
10/18: 55.6% 16/17: 94.1% 6/8: 75%
19/19 = 100% 14/14 = 100% 2/2: 100%
48/221 = 21.7% 110/388 = 28.4% 53/197 = 26.9%
Table 6 Comparison of malignancy rates per preoperative thyroid FNA diagnostic category between our center and
other published studies using the most malignant FNA per patient at our center
FNA Result Blansfield et al. Postma et al. Wu et al. Williams et al. Our study
Unsatisfactory 0/11 = 0% 0/0 = 0% 3/21 = 14.2% 10/55 = 18.2% 2/17 = 11.8%
Benign 3/44 = 6.8% 0/28 = 0%* 2/63 = 3.1%* 15/94 = 16.0% 4/22 = 18.0%
Inconclusive 25/85 = 29.4% 3/47 = 6%* 14/100 = 14.0% 55/208 = 26.4% 22/76 = 28.9%
Suspicious for malignancy 8/14 = 57.1% 5/6 = 83% 10/18: 55.6% 16/17: 94.1% 6/8: 75.0%
Malignant 27/29 = 93.1% 2/2 = 100% 19/19 = 100% 14/14 = 100% 2/2: 100%
Total 63/183 = 34.4% 10/83 = 12.0% 48/221 = 21.7% 110/388 = 28.4% 36/125 = 28.8%
*Fisher’s exact p < 0.05.
FNA: fine-needle aspiration.
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group two categories in at least one of the comparison
studies. Until all published data use uniform and current
classification, comparison will remain a challenge.
This study is retrospective and is therefore potentially
subject to confirmation bias. However, we did not have
the authority or the resources to randomize our FNAs
into two groups and outsource the “academic centre”
cohort to another centre. Ideally these retrospective data
support our concerns and open the door to resources
for future prospective randomized research.
Our FNAs are primarily done by our radiology depart-
ment under ultrasound-guidance. However, there is not
a department-wide standard for technique used and not
all FNAs were done with guidance. This could also be
seen as a limitation. A less skilled aspirator may see a
higher percentage of unsatisfactory biopsies. Biopsies
taken without ultrasound guidance may not even sample
the target nodule and may only get surrounding thyroid
tissue. Standardized guided aspiration should be the
standard at all centres, particularly when publishing data
and comparing to published norms.
Lastly, volume is obviously a limitation. Our study is
not adequately powered to compare to larger academic
studies. However, if assessing the accuracy of FNA done
in a low-volume community centre, a well-powered
study is virtually impossible if done at a single centre. A
multi-centre randomized trial is needed to truly assess
whether low-volume centres produce less accurate FNA
data in the workup of thyroid nodules.
Conclusions
FNA remains a key tool in the investigation of thyroid
nodules. Despite its use, surgeons continue to resect a
very high percentage of benign disease because of uncer-
tainty with respect to its malignant potential. Until a
more accurate non-invasive diagnostic test is developed,
it is important that we continue to refine our FNA tech-
nique to improve its accuracy. Regardless, clinical judg-
ment remains of paramount importance in interpreting
FNA results in the context of a given patient. Our reviewis the first Canadian community-based study to analyze
the utility of preoperative FNA in terms of final thyroid-
ectomy pathology. Despite our suspicion, our data do
not support our hypothesis that low-volume community
centre FNAs will be less accurate than those done in
academic centres. That being said, it is possible that our
study’s limitations prevented us from finding the real an-
swer. Our study does show statistically significant vari-
ability in FNA distribution between our study and all
three of the comparison community studies. It also
shows significantly higher malignancy rates in benign
FNA specimens between our centre and the three com-
munity centres. This variability may be the result of
study design; of discrepancies, inconsistencies in tech-
nique or in interpretation of the FNA itself; or of differ-
ence in regional practice patterns as all three were
international studies. Regardless, consistency is needed
in both the aspiration and interpretation of FNAs in all
centres. With consistent methodology, further prospect-
ive studies will be better able to address whether or not
high-volume academic centres can produce more accur-
ate and reliable FNA results in the workup of thyroid
nodules.
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